Jun 26, 2026 09:31AM
Jun 17, 2026 11:56AM
Jun 4, 2026 04:39PM
Jun 3, 2026 03:11AM
May 29, 2026 12:28PM
May 22, 2026 07:00AM
May 18, 2026 02:05PM Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
May 13, 2026 02:11PM
May 13, 2026 02:11PM
May 5, 2026 12:42PM
May 5, 2026 12:41PM
Apr 10, 2026 01:03PM
Apr 8, 2026 10:06AM
Apr 7, 2026 02:33PM Lupin Announces the Approval of Dapagliflozin Tablets in the United States
Mar 31, 2026 09:11AM
Mar 25, 2026 08:29AM
Feb 26, 2026 10:57AM
Feb 24, 2026 01:09PM
Feb 4, 2026 12:51PM
Feb 2, 2026 08:30AM
Nov 14, 2025 07:00AM Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
Oct 9, 2025 05:58AM
Oct 9, 2025 05:58AM
Sep 10, 2025 08:43AM
Sep 10, 2025 08:43AM
Jul 15, 2024 07:20AM
Jun 11, 2020 12:54AM
Jun 8, 2020 01:03AM US FDA Grants Mexiletine Orphan Drug Designation
Oct 11, 2017 07:10AM

326,213 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All